Literature DB >> 27308527

Does radiation-induced c-MYC amplification initiate breast oncogenesis?

Mark A Wade1, Felicity E B May1, Ken Onel2, James M Allan1.   

Abstract

The MYC (v-myc avian myelocytomatosis viral oncogene homolog; c-MYC) locus on chromosome 8q is susceptible to high-level amplification following exposure of human breast cells to ionizing radiation, and c-MYC amplification is a common feature of both radiogenic adenocarcinoma and radiogenic angiosarcoma of the breast. Taken together, these observations suggest common breast-specific susceptibility factors that predispose cells to amplification of this critical proto-oncogene and the development of radiogenic cancer in multiple tissue types of this radiosensitive organ.

Entities:  

Keywords:  MYC; adenocarcinoma; amplification; oncogene; radiosensitive

Year:  2015        PMID: 27308527      PMCID: PMC4845163          DOI: 10.1080/23723556.2015.1010950

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  10 in total

1.  BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Authors:  Jake E Delmore; Ghayas C Issa; Madeleine E Lemieux; Peter B Rahl; Junwei Shi; Hannah M Jacobs; Efstathios Kastritis; Timothy Gilpatrick; Ronald M Paranal; Jun Qi; Marta Chesi; Anna C Schinzel; Michael R McKeown; Timothy P Heffernan; Christopher R Vakoc; P Leif Bergsagel; Irene M Ghobrial; Paul G Richardson; Richard A Young; William C Hahn; Kenneth C Anderson; Andrew L Kung; James E Bradner; Constantine S Mitsiades
Journal:  Cell       Date:  2011-09-01       Impact factor: 41.582

2.  Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.

Authors:  Paula S Ginter; Juan Miguel Mosquera; Theresa Y MacDonald; Timothy M D'Alfonso; Mark A Rubin; Sandra J Shin
Journal:  Hum Pathol       Date:  2013-11-12       Impact factor: 3.466

3.  High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas. Further results from EORTC STBSG TL 01/01.

Authors:  Christoph Käcker; Alexander Marx; Katharina Mössinger; Frederike Svehla; Ulrike Schneider; Pancras Cornelis Wilhelmus Hogendoorn; Ole Steen Nielsen; Stefan Küffer; Christian Sauer; Cyril Fisher; Christian Hallermann; Jörg Thomas Hartmann; Jean-Yves Blay; Gunhild Mechtersheimer; Peter Hohenberger; Philipp Ströbel
Journal:  Genes Chromosomes Cancer       Date:  2012-09-25       Impact factor: 5.006

4.  Molecular changes in second primary lung and breast cancers after therapy for Hodgkin's disease.

Authors:  C Behrens; L B Travis; I I Wistuba; S Davis; A Maitra; E A Clarke; C F Lynch; B Glimelius; T Wiklund; R Tarone; A F Gazdar
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2000-10       Impact factor: 4.254

5.  Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.

Authors:  T Mentzel; H U Schildhaus; G Palmedo; R Büttner; H Kutzner
Journal:  Mod Pathol       Date:  2011-09-09       Impact factor: 7.842

6.  Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.

Authors:  Timothy Best; Dalin Li; Andrew D Skol; Tomas Kirchhoff; Sarah A Jackson; Yutaka Yasui; Smita Bhatia; Louise C Strong; Susan M Domchek; Katherine L Nathanson; Olufunmilayo I Olopade; R Stephanie Huang; Thomas M Mack; David V Conti; Kenneth Offit; Wendy Cozen; Leslie L Robison; Kenan Onel
Journal:  Nat Med       Date:  2011-07-24       Impact factor: 53.440

7.  Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.

Authors:  Tianhua Guo; Lei Zhang; Ning-En Chang; Samuel Singer; Robert G Maki; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2011-01       Impact factor: 5.006

Review 8.  Breast cancer risk among the survivors of atomic bomb and patients exposed to therapeutic ionising radiation.

Authors:  A Carmichael; A S Sami; J M Dixon
Journal:  Eur J Surg Oncol       Date:  2003-06       Impact factor: 4.424

9.  C-myc amplification in breast cancer: a meta-analysis of its occurrence and prognostic relevance.

Authors:  S L Deming; S J Nass; R B Dickson; B J Trock
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  c-MYC is a radiosensitive locus in human breast cells.

Authors:  M A Wade; N J Sunter; S E Fordham; A Long; D Masic; L J Russell; C J Harrison; V Rand; C Elstob; N Bown; D Rowe; C Lowe; G Cuthbert; S Bennett; S Crosier; C M Bacon; K Onel; K Scott; D Scott; L B Travis; F E B May; J M Allan
Journal:  Oncogene       Date:  2014-12-22       Impact factor: 9.867

  10 in total
  2 in total

1.  Radiotherapy-associated intra-abdominal angiosarcoma after prostatic adenocarcinoma: Case reports.

Authors:  David Parada Domínguez; Karla B Peña Gonzalez
Journal:  Mol Clin Oncol       Date:  2018-10-05

2.  Mutational landscape of radiation-associated angiosarcoma of the breast.

Authors:  Bryan J Thibodeau; Vincent Lavergne; Nayana Dekhne; Pamela Benitez; Mitual Amin; Samreen Ahmed; Jean L Nakamura; Philip R Davidson; Alice O Nakamura; Inga S Grills; Peter Y Chen; Jessica Wobb; George D Wilson
Journal:  Oncotarget       Date:  2018-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.